Abstract
We read with interest the recent paper from Premjeyanth V, et al. about the strong contribution of fecal calprotectin to detect mucosal inflammation in the gastrointestinal tract in patients with skin disorders. To adequately interpret the results of fecal calprotectin levels, Dermatologists have to take into account various issues when prescribing FC measurement in daily practice regarding the conditions of stool collection, sample storage and various factors influencing the measurement of this fecal marker.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.